HELEN KIDKA: Open Payments
NPI 1093581068 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 55 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $328 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $235 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $220 |
| Ardelyx, Inc. | 7 | $170 |
| SPR Therapeutics, Inc | 2 | $167 |
| PFIZER INC. | 4 | $78 |
| SCILEX PHARMACEUTICALS INC. | 4 | $64 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $50 |
| Bioventus LLC | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: RELISTOR, QULIPTA, IBSRELA, SPRINT PNS System, UBRELVY, NURTEC ODT, JOURNAVX, ZTLido.
Industry payments across CA — which companies pay providers there.
